CUSPIDI, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 56.434
AS - Asia 27.151
EU - Europa 17.799
SA - Sud America 3.868
Continente sconosciuto - Info sul continente non disponibili 2.159
AF - Africa 553
OC - Oceania 63
Totale 108.027
Nazione #
US - Stati Uniti d'America 52.510
SG - Singapore 9.798
CN - Cina 4.907
IT - Italia 4.785
HK - Hong Kong 4.713
VN - Vietnam 3.809
RU - Federazione Russa 3.478
CA - Canada 3.465
BR - Brasile 2.935
IE - Irlanda 1.993
UA - Ucraina 1.616
SE - Svezia 1.580
DE - Germania 1.229
BD - Bangladesh 981
GB - Regno Unito 905
FR - Francia 880
IN - India 589
FI - Finlandia 484
AR - Argentina 350
TR - Turchia 326
ID - Indonesia 299
IQ - Iraq 285
KR - Corea 281
MX - Messico 196
PK - Pakistan 173
EC - Ecuador 168
ZA - Sudafrica 159
NL - Olanda 139
CO - Colombia 132
JP - Giappone 132
SA - Arabia Saudita 132
PH - Filippine 112
AT - Austria 109
UZ - Uzbekistan 104
ES - Italia 98
PL - Polonia 95
VE - Venezuela 91
DK - Danimarca 79
MY - Malesia 77
CL - Cile 65
MA - Marocco 65
JM - Giamaica 58
EG - Egitto 56
KE - Kenya 56
TN - Tunisia 50
AU - Australia 48
PY - Paraguay 48
TH - Thailandia 45
BE - Belgio 43
CZ - Repubblica Ceca 43
CR - Costa Rica 42
NP - Nepal 40
ET - Etiopia 38
AE - Emirati Arabi Uniti 37
DZ - Algeria 32
JO - Giordania 29
PE - Perù 28
HN - Honduras 27
RO - Romania 27
TT - Trinidad e Tobago 27
AZ - Azerbaigian 26
GT - Guatemala 26
KZ - Kazakistan 26
OM - Oman 26
UY - Uruguay 24
IR - Iran 23
NG - Nigeria 22
PS - Palestinian Territory 22
BO - Bolivia 21
IL - Israele 21
LT - Lituania 21
TW - Taiwan 21
BG - Bulgaria 20
GR - Grecia 19
AL - Albania 17
DO - Repubblica Dominicana 16
KG - Kirghizistan 16
LB - Libano 16
RS - Serbia 16
NI - Nicaragua 15
PT - Portogallo 15
SN - Senegal 15
HU - Ungheria 14
NZ - Nuova Zelanda 14
CH - Svizzera 13
GE - Georgia 13
BA - Bosnia-Erzegovina 11
BY - Bielorussia 11
EU - Europa 11
PA - Panama 11
QA - Qatar 11
SY - Repubblica araba siriana 11
BH - Bahrain 10
LK - Sri Lanka 10
NO - Norvegia 10
PR - Porto Rico 10
SK - Slovacchia (Repubblica Slovacca) 10
SV - El Salvador 10
EE - Estonia 9
MD - Moldavia 9
Totale 105.740
Città #
Ann Arbor 7.848
Singapore 5.145
Hong Kong 4.662
Woodbridge 4.362
Fairfield 4.240
Ashburn 3.971
Houston 3.136
Toronto 2.830
San Jose 2.118
Dublin 1.874
Jacksonville 1.830
Wilmington 1.830
Milan 1.771
Seattle 1.655
Cambridge 1.399
Chandler 1.365
Dearborn 1.365
New York 1.233
Ho Chi Minh City 1.133
Princeton 1.004
Chicago 931
Hanoi 878
Santa Clara 821
The Dalles 775
Council Bluffs 754
Dallas 750
Beijing 667
Frankfurt am Main 655
Los Angeles 579
Hefei 534
Lauterbourg 497
Lawrence 479
Rome 455
Altamura 453
Nanjing 423
Moscow 328
San Diego 318
Lachine 310
São Paulo 269
Seoul 256
Buffalo 225
Boardman 191
Dong Ket 171
Shanghai 169
Guangzhou 156
Jakarta 154
Nanchang 146
Shenyang 145
Salt Lake City 142
Andover 139
Da Nang 138
Haiphong 130
Columbus 124
Phoenix 124
London 121
Hebei 120
Baghdad 116
Helsinki 110
Figino 109
Orem 108
Falls Church 95
Munich 95
Tianjin 94
Rio de Janeiro 93
Ottawa 92
Turin 92
Changsha 89
Norwalk 89
Tokyo 89
Tashkent 85
Jiaxing 81
Atlanta 78
Tampa 77
Detroit 75
Nuremberg 75
Quito 74
Brooklyn 71
Naples 69
Jinan 66
Dhaka 65
Hangzhou 65
Montreal 64
San Francisco 64
Chennai 62
Denver 62
Johannesburg 62
Warsaw 62
Vienna 61
Washington 60
Brasília 59
Can Tho 58
Miami 58
Biên Hòa 57
Philadelphia 57
Zhengzhou 55
Hải Dương 53
Lahore 53
Quận Bình Thạnh 52
Mexico City 51
Newark 51
Totale 71.551
Nome #
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study 602
Myocardial Mechanics in Acromegaly: A Meta-Analysis of Echocardiographic Studies 490
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 480
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age 388
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 384
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 377
Need for information and locus of control among hypertensive patients 367
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 357
Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension 347
Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects 346
Effects of different sodium intakes on the antihypertensive and renal effects of single oral doses of nifedipine in hypertensive patients 338
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 337
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 336
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials 335
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 335
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 334
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 333
Cardiopulmonary receptor regulation of renin release 328
The development of new antihypertensive drugs with specific properties for the treatment of established hypertension 325
Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients 316
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 315
Neurogenic abnormalities in masked hypertension 311
Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone 311
Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice 310
Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients 308
Self-Reported Weight and Height: Implications for Left Ventricular Hypertrophy Detection. An Italian Multi-Center Study 307
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 305
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 299
Effects of moderate low sodium/high potassium diet on essential hypertension: results of a comparative study 299
Structural alterations of the retinal microcirculation in the "prehypertensive" high-normal blood pressure state 296
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 294
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 290
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 290
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 289
Renal and antihypertensive effects of felodipine in hypertensive patients 288
Left ventricular geometry and diastolic function in the hypertensive heart: Impact of age 287
Prevalence and Correlates of Echocardiographic Left Atrial Enlargement in Hypertensive Outpatients in Clinical Practice 286
Extreme dipping: Always means nocturnal hypotension? 285
Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method 281
Treatment of hypertension: The ESH/ESC guidelines recommendations 281
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 280
New-onset left atrial enlargement in a general population 278
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 277
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 276
[Pseudo-Conn's syndrome after habitual ingestion of liquorice. Report on various clinical cases] 275
The association between 24-h blood pressure patterns and left ventricular mechanics 275
Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? 273
Echocardiography in clinical practice: The burden of arterial hypertension. A multicenter Italian survey 271
Elevated Blood Pressure And Cardiac Mechanics In Children And Adolescents: A Systematic Review And Meta-Analysis 270
Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: A tissue Doppler study in echocardiographic practice 269
Metabolic syndrome, left ventricular hypertrophy and carotid atherosclerosis in hypertension: A gender-based study 269
Hemodynamic, humoral and renal effects of the acute administration of nifedipine in hypertensive patients 268
The impact of arterial hypertension on left ventricular strain in patients with aortic stenosis and preserved ejection fraction. 268
How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? 266
Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients 264
Aortic root dilatation in hypertensive patients: A multicenter survey in echocardiographic practice 262
Comprendere l'ipertensione; percezioni della malattia e bisogno informativo in un campione di pazienti ipertesi 262
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes 261
Metabolic syndrome and multiple organ damage in essential hypertension 261
Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness 261
New onset left atrial dilatation in the general population: A quarter-century follow-up 259
Ambulatory heart rate and target organ damage in never-treated essential hypertensives 259
Nocturnal blood pressure in untreated essential hypertensives 259
Evaluating a tailored message intervention for improving hypertension outcomes 258
Blood pressure control in hypertension. Pros and cons of available treatment strategies 258
Association Between Arterial Stiffness, High Blood Pressure, and Hypertensive Phenotypes: Insights from the PAMELA Study 257
Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician? 257
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 256
SYMPATHETIC OVERDRIVE IN THE RESISTANT HYPERTENSIVE PHENOTYPE 256
Is blunted heart rate decrease at night associated with prevalent organ damage in essential hypertension? 255
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 253
Correlation between arterial pressure at rest and during effort and left ventricular mass in hypertensive patients who were never treated 253
Carotid atherosclerosis and cardiovascular risk stratification: role and cost-effectiveness of echo-Doppler examination in untreated essential hypertensives 252
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 251
Clinical evaluation of a new antihypertensive drug (Indapamide) 250
Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: Results from the Assessment Prognostic Risk Observational Survey (APROS) 248
Obesity and heart failure with preserved ejection fraction: a paradox or something else? 248
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 248
Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis 247
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 247
Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: Is the difference limited to obese hypertensives? 246
Is retinal arteriolar-venular associated with cardiac and extracardiac organ damage in essential hypertension? 246
Echocardiographic aortic root dilatation in hypertensive patients: a systematic review and meta-analysis 245
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 245
Incident Left Ventricular Hypertrophy in Masked Hypertension 245
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 243
Mitral deceleration index is associated with aortic root dilatation and not to biventricular structural changes in essential hypertension 243
Left atrial function in elite athletes: A meta-analysis of two-dimensional speckle tracking echocardiographic studies 242
Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study 241
How does subclinical hyperthyroidism affect right heart function and mechanics? 240
Metabolic syndrome and target organ damage: Role of blood pressure 239
Left ventricular hypertrophy and abdominal aorta size in essential hypertension 238
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 234
Evaluating a tailored message intervention for improving hypertension outcomes 234
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 233
How does blood pressure change in hypertensive patients with atrial fibrillation after successful electrical cardioversion? 233
Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure 232
Left and right atrial phasic function and deformation in untreated patients with prediabetes and type 2 diabetes mellitus. 232
Nocturnal hypertension and organ damage in dippers and nondippers 231
Masked hypertension: an independent predictor of organ damage 231
Totale 28.617
Categoria #
all - tutte 365.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 365.919


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.266 0 0 888 444 393 369 359 406 416 382 515 1.094
2022/20236.284 1.085 1.785 392 401 366 1.082 83 307 403 69 213 98
2023/20245.325 143 112 112 187 918 1.380 964 84 741 105 57 522
2024/202514.957 922 1.946 411 671 1.382 386 520 484 2.090 1.930 1.358 2.857
2025/202637.091 3.561 2.468 2.740 3.195 3.564 1.899 4.605 1.756 2.701 2.686 4.272 3.644
2026/20273.658 1.244 1.542 872 0 0 0 0 0 0 0 0 0
Totale 108.027